Document:

Asset Purchase Ageement

 Exhibit 10.41 
  
 ***Text Omitted and Filed Separately 
 Confidential Treatment Requested 
 Under C.F.R. §§ 200.80(b)(4) and 240.24b-2

  

  

  
 ASSET PURCHASE AGREEMENT 

 
 between 
  
 Applied Micro Circuits Corporation 
  
 (as “Buyer”), 
  
 and 
  
 International Business Machines Corporation, 
  
 (as “Seller”) 
  
 Dated: September 28, 2003 

  
 TABLE OF CONTENTS 
  

	 Article I.
	  	 Purchase and Sale of Assets
	  	5
			
	 1.1.
	  	 Transferred Assets and Transferred Contracts
	  	5
			
	 1.2.
	  	 Excluded Assets
	  	5
			
	 1.3.
	  	 Consideration
	  	5
			
	 1.4.
	  	 Assumed Liabilities
	  	6
			
	 Article II.
	  	 Closing
	  	6
			
	 2.1.
	  	 Closing Date
	  	6
			
	 2.2.
	  	 Closing Statement
	  	7
			
	 Article III.
	  	 Tax Matters
	  	7
			
	 3.1.
	  	 Allocation of Purchase Price
	  	7
			
	 3.2.
	  	 Filing of Returns and Payment of Taxes
	  	8
			
	 3.3.
	  	 Refunds and Credits
	  	8
			
	 3.4.
	  	 Transfer Taxes
	  	8
			
	 Article IV.
	  	 Additional Covenants and Agreements
	  	8
			
	 4.1.
	  	 Solicitation of Employees
	  	8
			
	 4.2.
	  	 Further Action
	  	9
			
	 4.3.
	  	 Post Closing Payments
	  	9
			
	 4.4.
	  	 Consents, Novations and Subcontracted Work
	  	9
			
	 4.5.
	  	 Product Warranty Services
	  	10
			
	 4.6.
	  	 Excluded Liabilities
	  	11
			
	 4.7.
	  	 Provision of Omitted Assets
	  	11
			
	 4.8.
	  	 Permitted Liens
	  	11
			
	 Article V.
	  	 Representations and Warranties of Buyer
	  	11
			
	 5.1.
	  	 Incorporation
	  	11
			
	 5.2.
	  	 Authority
	  	11
			
	 5.3.
	  	 No Conflict
	  	12
			
	 5.4.
	  	 Governmental Consents
	  	12
			
	 5.5.
	  	 No Broker
	  	12

  

 ii 

  

			
	 Article VI.
	  	 Representations and Warranties of Seller
	  	12
			
	 6.1.
	  	 Incorporation
	  	12
			
	 6.2.
	  	 Authority
	  	13
			
	 6.3.
	  	 No Conflict
	  	13
			
	 6.4.
	  	 Governmental Consents
	  	13
			
	 6.5.
	  	 No Broker
	  	13
			
	 6.6.
	  	 Title to Personal Property
	  	14
			
	 6.7.
	  	 Litigation
	  	14
			
	 6.8.
	  	 No Rights In Others To Transferred Assets
	  	14
			
	 6.9.
	  	 Contracts
	  	14
			
	 6.10.
	  	 Warranties
	  	14
			
	 6.11.
	  	 Other Information
	  	15
			
	 6.12.
	  	 Transferred Contract Consents
	  	15
			
	 6.13.
	  	 Revenues
	  	15
			
	 6.14.
	  	 Inventory
	  	15
			
	 Article VII.
	  	 Conditions to Buyer’s Obligations
	  	15
			
	 7.1.
	  	 Representations and Warranties
	  	15
			
	 7.2.
	  	 Consents, Approvals and Injunctions
	  	16
			
	 7.3.
	  	 Governmental Rule
	  	16
			
	 7.4.
	  	 Operative Agreements
	  	16
			
	 7.5.
	  	 Closing Documents
	  	16
			
	 7.6.
	  	 Proceedings
	  	16
			
	 Article VIII.
	  	 Conditions to Seller’s Obligations
	  	17
			
	 8.1.
	  	 Payment of Purchase Price
	  	17
			
	 8.2.
	  	 Representations and Warranties
	  	17
			
	 8.3.
	  	 Consents, Approvals and Injunctions
	  	17
			
	 8.4.
	  	 Operative Agreements
	  	17
			
	 8.5.
	  	 Closing Documents
	  	17
			
	 8.6.
	  	 Proceedings
	  	18
			
	 Article IX.
	  	 General Matters
	  	18
			
	 9.1.
	  	 Survival of Representations and Warranties
	  	18

  
  

 iii 

			
	 9.2.
	  	 Limitation of Liability
	  	18
			
	 9.3.
	  	 Public Announcements
	  	19
			
	 9.4.
	  	 Costs
	  	19
			
	 9.5.
	  	 [...***...]
	  	19
			
	 9.6.
	  	 Modification and Waiver
	  	19
			
	 9.7.
	  	 Governing Law
	  	20
			
	 9.8.
	  	 Notices
	  	20
			
	 9.9.
	  	 Bulk Sales
	  	21
			
	 9.10.
	  	 Assignment
	  	21
			
	 9.11.
	  	 Counterparts
	  	21
			
	 9.12.
	  	 No Third Party Beneficiaries
	  	21
			
	 9.13.
	  	 Entire Agreement
	  	21

  

			
	 Schedules:
	 	 	 	 
		
	 Schedule A
	 	 Additional Permitted Liens

		
	 Schedule 1.1.
	 	 Transferred Assets

		
	 Schedule 1.4.
	 	 Assumed Liabilities

		
	 Schedule 3.1.
	 	 Allocation of Purchase Price

		
	 Schedule 4.4.
	 	 Required Consents to Assignment/Novation

		
	 Schedule 6.7.
	 	 Litigation

		
	 Schedule 6.13.
	 	 Revenues

			
	 Exhibits:
	 	 	 	 
		
	 Exhibit A
	 	 Assignment and Assumption Agreement

		
	 Exhibit B
	 	 Bill of Sale

		
	 Exhibit C
	 	 Schedule of Disclosures and Exceptions

  
  

	*	 	Confidential Treatment Requested 

  
 iv 

 ASSET PURCHASE AGREEMENT 
  
 THIS ASSET PURCHASE AGREEMENT (the “Agreement”), executed and dated as of September 28, 2003, by and between
Applied Micro Circuits Corporation, a Delaware corporation (“Buyer”), and International Business Machines Corporation, a New York corporation (“Seller” or “IBM”). 
  
 W I T N E S S E
T H: 
  
 WHEREAS, Seller wishes to sell
certain Transferred Assets (as defined herein) and assign certain Transferred Contracts used in the development and sale of certain switch fabric products; and 
  

WHEREAS, Buyer wishes to purchase from Seller, and Seller wishes to sell and transfer to Buyer, the Transferred Assets and the Transferred
Contracts for the purchase price and subject to the terms and conditions hereinafter set forth. 
  
 NOW, THEREFORE, in consideration of the premises set forth above and the respective covenants, agreements, representations and warranties
hereinafter set forth, Buyer and Seller hereby agree as follows: 
  
 Definitions. 
  
 Certain
Definitions. As used in this Agreement, the following terms shall have the meanings specified below. 
  
 “Affiliate” shall mean, as to any Person, any other Person which is controlling, controlled by or under common control with such Person.

  
 “Allocation Statements” shall have the
meaning set forth in Section 3.1. 
  
 “Assumed
Liabilities” shall have the meaning set forth in Section 1.4. 
  
 “Assumption Agreement” shall mean the Assignment and Assumption Agreement in the form set out in Exhibit “A” to be entered into by the Buyer and the Seller on the Closing Date and by which Buyer assumes the
Assumed Liabilities. 
  
 “Bill of Sale” shall
mean the Bill of Sale in the form set out in Exhibit “B” to be entered into by the Buyer and Seller on the Closing Date. 
  

 1 

 “Burdensome Condition” shall mean any action taken, or credibly threatened, by or before
any Governmental Authority or other Person to challenge the legality of the transactions contemplated by the Operative Agreements or that would otherwise deprive a Party of the material benefit of any such transaction, including (i) the pendency of
an investigation by a Governmental Authority (formal or informal), (ii) the institution of any litigation, or threat thereof, (iii) an order by a Governmental Authority of competent jurisdiction preventing consummation of the transactions
contemplated by the Operative Agreements or placing material conditions or limitations upon such consummation, or (iv) the issuance of any subpoena, civil investigative demand or other request for documents or information relating to such
transactions which request is unreasonably burdensome in the reasonable judgment of the applicable Person. 
  
 “Closing” shall have the meaning set forth in Section 2.1. 
  
 “Closing Date” shall have the meaning set forth in Section 2.1. 
  
 “Closing Statement” shall have the meaning set forth in
Section 2.2. 
  
 “Code” shall have the meaning
set forth in Section 3.1. 
  
 “Confidentiality
Agreement” shall mean that [...***...]. 
  
 “Custom Sales Agreement” shall mean the [...***...]. 
  
 “Date of Execution” shall mean the date this Agreement and the other Operative Agreements identified for signature in accordance with their terms on that date are signed. 
  
 “Disclosure Schedule” shall have the meaning set forth in
the Schedule of Disclosures and Exceptions to this Agreement. 
  
 “Effective Date” shall mean the time the Closing has been completed. 
  
 “Final Determination” shall mean (i) in respect of U.S. Federal income taxes a “determination” as defined in Section 1313(a) of the Code or the execution of an Internal Revenue Service Form
870-AD, and (ii) in respect of Taxes other than U.S. Federal income taxes, any final determination of liability in respect of a Tax which determination, under applicable law, is not subject to further appeal, review or modification through
proceedings or otherwise (including by reason of the expiration of a statute of limitations or a period for the filing of claims for refunds, amended returns or appeals from adverse determinations). 
  

	*	 	Confidential Treatment Requested 

  
 2 

 “Framework Agreement” shall mean [...***...]. 
  
 “Governmental Actions” shall mean any authorizations,
consents, approvals, waivers, exceptions, variances, franchises, permissions, permits, and licenses of, and filings and declarations with, Governmental Authorities, including the expiration or termination of waiting periods imposed under the HSR
Act. 
  
 “Governmental Authority” shall mean any
applicable Federal, state, local or foreign court, governmental or administrative agency or commission or other governmental agency, authority, instrumentality or regulatory body of competent jurisdiction. 
  
 “Governmental Rule” shall mean any applicable statute, law,
treaty, rule, code, ordinance, regulation or order of any Governmental Authority or any judgment, decree, injunction, writ, order or like action of any Federal, state, local or foreign court, governmental or administrative agency or commission, or
other governmental agency, authority, instrumentality or regulatory body, arbitrator or other judicial tribunal of competent jurisdiction. 
  
 “HSR Act” shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. 
  
 “In Scope Products” shall have the meaning ascribed to it
under the Intellectual Property Agreement. 
  
 “Intellectual Property Agreements” shall mean the agreements entitled (i) Intellectual Property Agreement and (ii) Patent License Agreement, each between the Seller and Buyer, entered into on the Date of Execution.

  
 “Liens” shall mean pledges, claims, liens,
charges, encumbrances and security interests of any kind whatsoever. 
  
 “Limitation Amount” shall have the meaning set forth in Section 9.2. 
  
 “Operative Agreements” shall mean this Agreement, the Intellectual Property Agreements, the Custom Sales Agreement, the Transition Services Agreement, the Framework Agreement, the Bill of Sale, and
the Assumption Agreement. 
  
 “Parties” shall
mean Buyer and Seller. 
  
 “Party” shall mean
Buyer or Seller, as applicable. 
  
 “Permitted
Liens” shall mean: (i) Liens for Taxes, assessments and governmental charges due and being contested in good faith by Seller; (ii) any Liens, that individually or in the aggregate, are not substantial in character or amount or do not
materially adversely affect the value of the Transferred Assets; (iii) Liens for Taxes either not due and 
  

	*	 	Confidential Treatment Requested 

  
 3 

 payable or due but for which notice of assessment has not been given, or which may thereafter be paid without penalty;
(iv) any statutory Liens claimed or held by any Governmental Authority that have not at the time been filed or registered against title to the Transferred Assets or that relate to obligations that are not due or delinquent; (v) any imperfections of
title or similar Liens, if any, which imperfections of title or similar Liens do not materially impair the use of the assets to which they relate; (vi) Liens created or granted by Buyer or otherwise arising in respect of claims against the Buyer
(and not the Seller); and (vii) any Liens described on Schedule A. 
  
 “Person” shall mean any individual, firm, corporation, partnership, limited liability company, trust, joint venture, Governmental Authority or other entity, and shall include any successor (by merger or otherwise) of such
entity. 
  
 “Purchase Price” shall have the
meaning set forth in Section 1.3. 
  
 “Subcontracted
Work” shall have the meaning set forth in Section 4.4. 
  
 “Subsidiary” of any Person shall mean a corporation, company, or other entity (i) more than fifty percent (50%) of whose outstanding shares or securities (representing the right to vote for the election of directors or
other managing authority) are, or (ii) which does not have outstanding shares or securities (as may be the case in a partnership, limited liability company, joint venture or unincorporated association), but more than fifty percent (50%) of whose
ownership interest representing the right to direct, or cause the direction of, the management or policies of such entity is, now or hereafter owned or controlled, directly or indirectly, by such Person, but such corporation, company or other entity
shall be deemed to be a Subsidiary only so long as such ownership or control exists. 
  
 “Tax” or “Taxes” shall mean all taxes, imposts, duties, withholdings, charges, fees, levies, or other assessments imposed by any Governmental Authority or taxing authority, whether domestic
or foreign (including but not limited to, income, excise, property, sales, use, transfer, conveyance, payroll or other employment related tax, license and registration fees, ad valorem, value added, withholding, social security, national insurance
(or other similar contributions or payments), franchise, severance or estimated severance, stamp taxes, taxes based upon or measured by capital stock, net worth or gross receipts and other taxes), together with all interest, fines, penalties and
additions attributable to or imposed with respect to such amounts and any obligations under any agreement or arrangements with any Person with respect to such amounts. 
  
 “Transferred Assets” shall mean [...***...]. 
  
 “Transferred Contracts” shall mean [...***...].

  
 “Transition Services Agreement” shall mean
[...***...]. 
  

	*	 	Confidential Treatment Requested 

  
 4 

 Article I. Purchase and Sale of Assets. 
  
 1.1 Transferred Assets and Transferred Contracts. Upon the
terms and subject to the conditions hereof, as of the Closing Date, Seller hereby sells, transfers, conveys, assigns and delivers to Buyer, and Buyer hereby purchases and accepts from Seller, all right, title and interest of Seller in and to the (i)
Transferred Assets (in the case of inventory, subject to the Closing Statement adjustments) and (ii) the rights and benefits associated with the Transferred Contracts (subject to the provisions of Section 4.4). The Transferred Assets and the
Transferred Contracts (subject to Section 4.4 and any obligations of confidentiality) will be made available on the Closing Date, where then located as identified by Seller to Buyer in writing, it being understood and agreed that for (a) any
equipment on loan to a customer and located at a customer’s facility, such equipment will remain at the customer’s facililty pursuant to, and in accordance with, the terms and conditions of the applicable loan agreement between Seller and
customer and (b) for all Transferred Assets other than those in the foregoing subsection (a), Seller will, on the Effective Date, ship (Ex Works Seller’s facility) such Transferred Assets to the Buyer. 
  
 1.2 Excluded Assets. Notwithstanding anything to the contrary
in this Agreement, any assets which are not Transferred Assets or Transferred Contracts will be retained by Seller and are excluded from the transaction, including (i) any interest in any contractual arrangement with any Affiliate of Seller, (ii)
any interests of Seller in real property or any fixtures, and (iii) all accounts receivables in respect of goods or services to the extent shipped or provided by Seller or Seller’s Affiliates, directly or indirectly, prior to the end of the
Closing Date. All intellectual property matters related to this transaction are addressed exclusively in the Intellectual Property Agreements and no intellectual property matters are included in the subject matter of this Agreement. 
  
 1.3 Consideration. The purchase price to be paid by Buyer to
Seller for the Transferred Assets and the Transferred Contracts shall be [...***...] (the combined amounts, hereafter referred to as the “Purchase Price”). In addition to the Purchase Price and Buyer’s assumption of
Assumed Liabilities under the terms and subject to the conditions of this Agreement, the consideration to be paid at Closing for the matters set forth in the Intellectual Property Agreements shall be [...***...]. Therefore, on the
Closing Date, Buyer shall pay to Seller the aggregate amount set forth in this Section 1.3, which is [...***...] , by electronic funds transfer, such sum in immediately available funds. All payments shall be made in United States
dollars. The Purchase Price shall be paid to the following account: 
  
 [...***...] 
  

	*	 	Confidential Treatment Requested 

  
 5 

 The consideration for the Intellectual Property Agreements shall be paid to the following account: 
  
 [...***...] 
  
 1.4 Assumed Liabilities. Upon the terms and subject to the
conditions hereof, as of the Closing, Seller will assign and transfer to Buyer, and Buyer will accept and assume, and thereafter shall fully perform and discharge, on a timely basis and in accordance with their respective terms and conditions, only
(a) the liabilities, obligations and commitments of Seller listed on Schedule 1.4. hereto (including the Transferred Contracts) but only to the extent such obligations (i) do not arise from or relate to any breach by Seller of any provision of any
of such Transferred Contracts and (ii) do not arise from or relate to any event, circumstance or condition occuring or existing on or prior to the Closing Date that, with notice or lapse of time, would constitute or result in a breach of any of such
Transferred Contracts, (b) any warranty obligations of Seller for any In Scope Products sold, by Seller to any customers or distributors prior to Closing, including but not limited to, those warranty obligations listed in Schedule 1.4 hereto, and
(c) the existing software maintenance obligations of Seller listed in Schedule 1.4 with respect to software licensed, by Seller prior to Closing, in connection with any In Scope Product, it being understood, in the case of (a) and (b) above, that
Buyer shall perform such warranty or maintenance service obligations on behalf of and for Seller and Buyer will have no direct obligation or liability to Seller’s customers or distributors on account of such warranty or maintance obligations of
the Seller or its Affiliates. (collectively, subsections (a), (b), (c) referred to as the “Assumed Liabilities”). Except for the Assumed Liabilities, Buyer is not assuming any liability, obligation or commitment of any nature of Seller
related to Seller’s or its Affiliates’ operations or sales of the In Scope Product prior to the Closing date, and any such liability, obligation or commitment of the Seller or its Affiliates shall be an Excluded Liability. For purposes of
this Agreement, all liabilities of Seller and any of its Affiliates not expressly listed in the definition of Assumed Liabilities, or expressly excluded from the definition of Assumed Liabilities under subsections (i) and (ii) of this Section 1.4,
are referred to as “Excluded Liabilities.” 
  
 Article II. Closing 
  
 2.1
Closing Date. Subject to the conditions set forth in Articles VII and VIII below, the closing of the transaction provided for in this Agreement (the “Closing”) shall take place at the offices of Seller on or before September
30, 2003 (the “Closing Date”). All transactions provided for herein to occur on and as of the Closing Date shall be deemed to have occurred simultaneously and to be effective as of 11:59 p.m. (Eastern Standard Time) on the Closing Date.

  

	*	 	Confidential Treatment Requested 

  
 6 

 Notwithstanding anything to the contrary contained herein or in any of the Operative Agreements, in the event that the
Closing shall not have been consummated by September 30, 2003, time being of the essence, then this Agreement and all other Operative Agreements (other than the Confidentiality Agreement) shall be deemed automatically terminated and null and void,
without further action by either party, and there shall be no right, liability or obligation on the part of Seller or Buyer, except that Buyer shall immediately return to Seller any deliverables or other items Seller may have previously provided by
Seller to Buyer under any of the Operative Agreements 
  
 2.2
Closing Statement. [...***...] days after Closing, the Seller, with reasonable assistance from the Buyer, will prepare and deliver to Buyer a closing statement for the physical assets that constitute the Transferred
Assets (the “Closing Statement”), as of the Closing Date. The purpose of the Closing Statement is to correctly reflect any changes in the listing of the inventory included in the Transferred Assets, which occur in the ordinary course of
Seller’s business, between the Date of Execution and the Closing . The Closing Statement shall become final and binding upon the Parties unless Buyer gives written notice of its disagreement, which disagreement shall be based solely on the
accuracy of the number of items included on or excluded from the Closing Statement, within [...***...] days following Buyer’s receipt of the Closing Statement. Any such notice shall specify in reasonable detail the nature of any
disagreement so asserted. Unless the Buyer agrees in writting, in no event will any assets be added to the list of Transferred Assets. In no event will any adjustment be made to the Purchase Price pursuant to this section. 
  
 Article III. Tax Matters 
  
 3.1 Allocation of Purchase Price. Except as otherwise required
pursuant to a Final Determination, Buyer and Seller agree to act in accordance with the allocations of the Purchase Price set forth in Schedule 3.1 (the “Allocation Statements”) for all Tax purposes, including for purposes of any Returns,
including any forms or reports (including IRS Form 8594) required to be filed pursuant to Section 1060 of the relevant version of the Internal Revenue Code (the “Code”) or any comparable provision of local, state or foreign law, to refrain
from taking any position inconsistent with any such Return or the Allocation Statements, and to cooperate in the preparation of any such Section 1060 or comparable forms or reports and to timely file such Section 1060 or comparable forms or reports
in the manner required by applicable law. 
  
 [...***...] shall
prepare the Form 8594 under Section 1060 of the Code based on the Allocation Statements and deliver such form and all documentation used in the preparation and support of such form to [...***...] within [...***...] after
the Closing Date. 
  

	*	 	Confidential Treatment Requested 

  
 7 

 Buyer and Seller shall, and shall cause their respective Affiliates to cooperate with respect to Tax matters.

  
 3.2 Filing of Returns and Payment of Taxes.
[...***...] shall prepare and file, or cause to be prepared and filed, with the appropriate authorities all Tax returns, reports and forms (herein “Tax Returns”) and shall pay, or cause to be paid, when due all Taxes relating to
the Transferred Assets attributable to any taxable period which ends on or prior to the Closing Date (herein “Pre-Closing Tax Period”). [...***...] shall prepare and file, or cause to be prepared and filed, with the appropriate
authorities all Tax Returns, and shall pay, or cause to be paid, when due all Taxes relating to the Transferred Assets attributable to taxable periods which are not part of the Pre-Closing Tax Period. If, in order to properly prepare its Tax Returns
or other documents required to be filed with Governmental Authorities, it is necessary that a party be furnished with additional information, documents or records relating to the Transferred Assets, both Seller and Buyer agree to use reasonable
efforts to furnish or make available such non-privileged information at the recipient’s request, cost and expense provided, however, that no party shall be entitled to review or examine the Tax Returns of any other party. 
  
 For purposes of this Section 3.2, in the case of any Taxable period that
includes (but does not end on) the Closing Date (a “Straddle Period”), the Taxes for the Pre-Closing Tax Period shall be computed as if the Pre-Closing Tax Period ended as of the close of business on the Closing Date and the amount of
Taxes for taxable periods that are not party of the Pre-Closing Tax Period shall be the excess, if any, of (x) the Taxes for the Straddle Period over (y) the Taxes for the Pre-Closing Tax Period. 
  
 3.3 Refunds and Credits. Any refunds and credits attributable
to the Pre-Closing Tax Period shall be for the account of the [...***...] and any refunds and credits attributable to the period that is not part of the Pre-Closing Tax Period shall be for the account of the [...***...]. 
  
 3.4 Transfer Taxes. All Taxes that are transfer, documentary,
sales, use, registration, value-added or real estate transfer taxes, or any similar taxes and related fees incurred in connection with this Agreement and the other Operative Agreements and the transactions contemplated hereby and thereby shall be
borne [...***...]. To the extent legally able to do so, Buyer and Seller shall cooperate with each other to obtain exemptions from such Taxes, provided that neither Party shall be obligated to seek any exemption that would require any
governmental audit of its books and records. 
  
 Article IV.
Additional Covenants and Agreements 
  
 4.1
Solicitation of Employees. Buyer agrees that, for a period of [...***...] from the Closing Date, it will not, without the Seller’s written consent, directly or indirectly, solicit for employment any employee of Seller
(or any of its Subsidiaries) employed in the [...***...] 
  

	*	 	Confidential Treatment Requested 

  
 8 

 
[...***...] (other than the Transferred Employees as such term is defined under the Business Sale Agreement, which is attached to the Framework
Agreement), as amended if so, any time during the period described in this Section 4.1, 
  
 Seller agrees that, for a period of [...***...] from the Closing Date, [...***...] will not, without the Buyer’s written consent, directly or indirectly, solicit for employment [...***...]. For
purposes of this Section 4.1, the term “solicit for employment” shall not include general employment advertising or the use of any independent employment agency or search firm not specifically directed to employees of the other Party (or
any of its Subsidiaries). 
  
 4.2 Further Action.
The Parties each agree to execute and deliver after the Closing Date such other documents, certificates, agreements and other writings and to take such other actions as may be necessary or desirable, in the opinion of the Parties’ counsel,
in order to consummate or implement expeditiously the transactions contemplated hereby. 
  
 4.3 Post-Closing Payments. The Parties acknowledge that, for a period of [...***...] after the Closing Date, Seller may make payments to third parties on behalf of Buyer associated with the
Transferred Assets and Assumed Liabilities. Buyer agrees to reimburse Seller for such payments [...***...] receipt of an invoice from Seller provided [...***...]. Seller shall invoice Buyer monthly on the
[...***...] of each month. If Buyer disputes such invoice on the basis that such payment did not relate to the Transferred Assets or the Assumed Liabilities, Buyer shall, within [...***...] of receiving such invoice, give
notice to Seller of such dispute and the Parties shall attempt to immediately resolve such dispute. All amounts payable by Buyer to Seller pursuant to this Section 4.3, shall be paid in immediately available funds in U.S. dollars to Seller’s
account set forth in Section 1.3. Any payments to third parties on behalf of Buyer associated with the Transferred Assets and Assumed Liabilities after the expiration of the [...***...] period require Buyer’s prior written consent.

  
 4.4 Consents, Novations and Subcontracted Work.
Buyer and Seller shall use reasonable efforts to obtain, as soon as practicable, all requisite consents to transfers, assignments and novations, as the case may be, of all of the Transferred Assets, Transferred Contracts and the Assumed
Liabilities. Buyer shall cooperate with Seller (including, where necessary, entering into appropriate instruments of assumption as shall be agreed upon) to have Seller released from all liability to the contract counterparty with respect to the
Assumed Liabilities, and the Parties will each solicit such releases concurrently, in a manner acceptable to the Parties, with the solicitation of consents from third parties to the transfer, assignment and novation of the Transferred Assets,
Transferred Contracts, and the Assumed Liabilities; 

  

	*	 	Confidential Treatment Requested 

  
 9 

 
provided, that neither Party shall be required to grant any additional consideration to any third party in order to obtain any such consent, novation,
assignment or release. For any Assumed Liabilities for which Seller has any secondary liability to third parties, Buyer shall, upon prior written notice from Seller, provide Seller reasonable access and information in order for Seller to ascertain
continuing compliance by Buyer with all contract terms and conditions applicable thereto. The consents to transfers, assignments and novations identified by the Parties as of the Date of Execution, if any, are listed on Schedule 4.4. If any such
required consents and novations can be secured with the incurring of reasonable costs, Seller agrees to pay any such costs (excluding those of the Buyer). Where a Transferred Contract has not been assigned to Buyer on the Closing Date, the Parties
agree to enter into such other arrangements, effective on the Closing Date, with respect to the underlying rights and obligations as shall permit Buyer to perform the obligations of Seller thereunder, as a subcontractor or otherwise, and Buyer to
obtain the material benefit thereof (the “Subcontracted Work”) without regard to any costs or expenses incurred by the Seller in connection thereto other than (i) any costs or expenses to which Seller is entitled to payment or
reimbursement under any of the other Operative Agreements or (ii) costs and expenses that would have been incurred by the Buyer had the applicable Transferred Contract been assigned to the Buyer on the Closing Date ; and until the requisite consents
and novations are obtained, such obligations will not be deemed to be included in the Assumed Liabilities and nothing contained herein will be deemed to create an obligation or relationship that would constitute a breach of the contract underlying
such rights and obligations. For the avoidance of doubt, “material benefit” as used in this Section 4.4 shall expressly include any payments received by Seller under the Transferred Contracts after the Closing Date for any products shipped
under the Transferred Contracts after the Closing Date (i) directly by Buyer or (ii) by Seller on behalf of Buyer using inventory, including that listed on Schedule 1.1, provided, directly or indirectly, by Buyer. Buyer agrees to diligently perform
and discharge the obligations of Seller in connection with the Subcontracted Work directly, or indirectly through Seller, as applicable and to the extent that consents to transfer, assignment and novation are obtained after the Closing, the Parties
agree that such obligations will no longer be considered to be Subcontracted Work after such time, but will instead be deemed to be Assumed Liabilities for all purposes of this Agreement. 
  
 4.5 Product Warranty Services. Seller shall pay Buyer within
[...***...] after receipt of invoice from Buyer, for the actual reasonable cost of (a) warranty services performed by Buyer with respect to In Scope Products sold by Seller or its Affiliates prior to the Closing Date and (b) software
maintenance services performed by Buyer with respect to any software maintenance obligations of Seller listed in Schedule 1.4 with respect to software licensed by Seller prior to the Closing Date. Within [...***...] after the Closing
Date, Buyer and Seller shall establish a reasonable mutually agreeable process pursuant to which Buyer shall provide such warranty services, it being understood that [...***...]. At a minimum, such process shall address establishing
warranty run rates and failure rate expectations for each product. In addition, neither Buyer’s obligation to provide such warranty services, nor Seller’s obligation to pay for such warranty services, shall cover claims occurring after the
maximum applicable warranty period. 
  

	*	 	Confidential Treatment Requested 

  
 10 

 4.6 Excluded Liabilities. Seller acknowledges and agrees that Seller shall retain
responsibility for the Excluded Liabilities and that neither Buyer nor any of Buyer’s Affiliates shall have any liability or obligation for any such Excluded Liabilities. 
  
 4.7 Provision of Omitted Assets. If within [...***...] after the Closing Date of this Agreement
the Buyer or Seller believes that certain tangible assets or material contracts (other than any vendor contracts, distributor contracts, or any contracts regarding intellectual property matters) exclusively or primarily used in the sale of the In
Scope Products as of the Closing Date were omitted from Schedule 1.1 or Schedule 1.4, respectively, then the Parties will work in good faith to agree upon such omitted assets (the “Omitted Assets”). Once identified and agreed to, the
Parties will, subject to Section 4.4, amend the necessary documents and the Seller shall, at its sole expense, promptly deliver (or transfer in the case of any contracts) such Omitted Assets to Buyer so as to remedy such error or omission. So long
as there is no dispute as to whether a particular asset is an Omitted Asset, and the Parties have amended the necessary documents and the Seller has promptly transferred to Buyer such Omitted Assets, Seller shall have no further obligation or
liability to Buyer regarding such Omitted Assets. 
  
 4.8
Permitted Liens. Seller shall reimburse Buyer for the actual reasonable costs incurred by Buyer to discharge any Permitted Lien existing as of the Closing Date that adversely affects the value or Buyer’s use of a Transferred Asset;
provided, however, that Buyer must first give Seller at least [...***...] prior written notice of Buyer’s intention to discharge the Permitted Lien and an opportunity for Seller, at its option and expense, to attempt to discharge
the underlying Permitted Lien during such [...***...] period; provided further that Seller shall have no obligation under this Section 4.8 to discharge any Lien that is created or granted by Buyer. 
  
 Article V. Representations and Warranties of Buyer 

 
 Buyer hereby represents and warrants, as of the date of the Agreement and
of the Closing Date, to Seller as follows: 
  
 5.1
Incorporation. Buyer is a duly organized and validly existing corporation in good standing under the laws of the State of Delaware, with all requisite corporate power and authority to own its properties and conduct its business.

  
 5.2 Authority. Buyer has the requisite corporate
power and authority to execute and deliver each of the Operative Agreements and to perform its obligations under each such agreement. Each of the Operative Agreements has been duly and validly authorized, executed and delivered by Buyer and
constitutes the valid and binding agreement of Buyer in accordance with its respective terms. No other corporate proceedings on the part of Buyer are necessary to authorize the Operative Agreements and the transactions contemplated thereby.

  

	*	 	Confidential Treatment Requested 

  
 11 

 5.3 No Conflict. The execution and delivery by Buyer of each of the Operative Agreements
does not, and the performance of its obligations thereunder, will not: 
  
 (a) conflict with, or result in a breach of, any of the provisions of Buyer’s articles of incorporation or by-laws; 
  
 (b) breach, violate or contravene any Governmental Rule, or create any right of termination or acceleration or encumbrance, that, singly or in the
aggregate, would have a material adverse effect on the authority or ability of Buyer to perform its obligations under this Agreement, the Confidentiality Agreement, the Custom Sales Agreement, the Intellectual Property Agreements, and the Assumption
Agreement or the Assumed Liabilities; and 
  
 (c) conflict in any
respect with, or result in a breach of or default under, any contract, license, franchise, permit or any other agreement or instrument to which Buyer is a Party or by which Buyer or any of its properties may be affected or bound that, singly or in
the aggregate, would have a material adverse effect on the authority or ability of Buyer to perform its obligations under this Agreement, the Confidentiality Agreement, the Custom Sales Agreement, the Intellectual Property Agreements, and the
Assumption Agreement or the Assumed Liabilities. 
  
 5.4
Governmental Consents. Other than compliance with the HSR Act pre-notification requirements, if required, no material consent, approval or authorization of, or designation, declaration or filing with, any Governmental Authority on the
part of Buyer is required in connection with the execution or delivery by Buyer of this Agreement, the Intellectual Property Agreements, or the Assumption Agreement, or the consummation by Buyer of the transactions contemplated by any of the
foregoing. 
  
 5.5 No Broker. Buyer has not engaged
any corporation, firm or other Person who is entitled to any fee or commission as a finder or a broker in connection with the negotiation of the Operative Agreements or the consummation of the transactions contemplated thereby, and Buyer shall be
responsible for all liabilities and claims (including costs and expenses of defending against same) arising in connection with any claim by a finder or broker that it acted on behalf of Buyer in connection with the transactions contemplated thereby.

  
 Article VI. Representations and Warranties of Seller

  
 Except as set forth on the disclosure schedule delivered
by Seller to Buyer (the “Disclosure Schedule”), Seller hereby represents and warrants, as of the date of the Agreement and of the Closing Date, to Buyer as follows: 
  
 6.1 Incorporation. Seller is a duly incorporated and validly existing corporation in good standing under the
laws of the State of New York, with all requisite corporate power and authority to own its properties and conduct its business, and is duly qualified in each jurisdiction 

  

 12 

 
in which its ownership of property requires such qualification except where the failure to so qualify would not have a material adverse effect upon the
Transferred Assets. 
  
 6.2 Authority. Seller has
the requisite corporate power and authority to execute and deliver the Operative Agreements and to perform its obligations under each of the foregoing. Each of the Operative Agreements has been duly and validly authorized, executed and delivered by
Seller and constitutes the valid and binding agreement of Seller in accordance with its respective terms. No other corporate proceedings on the part of Seller are necessary to authorize the Operative Agreements and the transactions contemplated by
any of the foregoing. 
  
 6.3 No Conflict. The
execution and delivery by Seller of each of the Operative Agreements does not, and the performance by Seller of its obligations thereunder will not: 
  
 (a) conflict with, or result in a breach of, any of the provisions of its Articles of Incorporation or By-laws; 
  
 (b) breach, violate or contravene any Governmental Rule, or create any right
of termination or acceleration or encumbrance, that, singly or in the aggregate, would have a material adverse effect on (i) its authority or ability to perform its obligations under this Agreement, the Confidentiality Agreement, the Custom Sales
Agreement, the Intellectual Property Agreements, the Assumption Agreement or the Bill of Sale; or (ii) the Transferred Assets; and 
  
 (c) conflict in any respect with, or result in a breach of or default under, any contract, license, franchise, permit or any other agreement or instrument
to which it is a party or by which it or any of the Transferred Assets may be bound that, singly or in the aggregate, would have a material adverse effect on (i) its authority or ability to perform its obligations under this Agreement, the
Confidentiality Agreement, the Custom Sales Agreement, the Intellectual Property Agreements, the Assumption Agreement or the Bill of Sale; or (ii) the Transferred Assets (except for agreements and instruments that require the consent or approval of
a third party for the transactions contemplated by this Agreement). 
  
 6.4 Governmental Consents. Other than compliance with the HSR Act pre-notification requirements, if required, no material consent, approval or authorization of, or designation, declaration or filing with, any Governmental
Authority on the part of Seller is required in connection with the execution or delivery by Seller of the Operative Agreements or the consummation by Seller of the transactions contemplated by any of the foregoing. 
  
 6.5 No Broker. Seller has engaged no corporation, firm or other
Person who is entitled to any fee or commission as a finder or a broker in connection with the negotiation of the Operative Agreements or the consummation of the transactions contemplated thereby, and Seller shall be responsible for all liabilities
and claims (including costs and expenses of defending against same) arising in connection with any claim by a finder or broker that it acted on behalf of Seller in connection with the transactions contemplated thereby. 
  

 13 

 6.6 Title to Personal Property. Seller has good and marketable title to all tangible
personal property listed on Schedule 1.1 hereto, free and clear of any Liens other than Permitted Liens. At the Closing, Seller will transfer to the Buyer good and marketable title to all Transferred Assets, free and clear of any Liens other than
Permitted Liens. 
  
 6.7 Litigation. Except as
disclosed on Schedule 6.7, there are no actions, suits, proceedings or investigations pending or, to Seller’s knowledge, threatened in a writing to Seller against or directly affecting the Transferred Assets, at law or in equity, including any
administrative proceedings or condemnation actions with any regulatory authority, which in the aggregate would have a material adverse effect on the Transferred Assets. There is no existing default by Seller with respect to any judgment, order,
writ, injunction or decree of any Governmental Authority or arbitrator that materially adversely affects the Transferred Assets. 
  
 6.8 No Rights In Others To Transferred Assets. Neither Seller nor any Affiliate of Seller is party to any outstanding contracts or other
arrangements giving any Person any present or future right to require Seller to transfer to any Person any ownership or possessory interest in, or to grant any lien on, any of the Transferred Assets, other than pursuant to this Agreement.

  
 6.9 Contracts. Schedule 1.4. contains a true and
complete list of all Transferred Contracts. Seller has performed or is performing all material obligations required to be performed by it under such contracts and is not (with or without notice, lapse of time or both) in breach or default in any
material respect thereunder; and, to the knowledge of Seller, no other party to any of such contracts is (with or without notice, lapse of time or both) in breach or default in any material respect thereunder. Except for any such contracts that have
expired as of the Closing Date, the contracts listed on Schedule 1.4 remain in full force and effect, and [...***...], Seller has not received any notice or other written communication from the other contracting party that IBM is in
possible breach or default of any obligation thereunder. 
  
 [...***...], Seller used all commercially reasonable efforts to identify all material: sales contracts; outbound software licenses; equipment loan agreements; and vendor contracts (other than any contracts relating to
development or intellectual property matters.) of Seller that are exclusively or primarily related to those certain In Scope Products (as such capitalized term is defined in Schedule “A” of the IPA) being sold by Seller as of the Closing
Date; provided, however, that nothing in the foregoing sentence shall be deemed or interpreted to modify Section 4.7 or the definition or scope of Transferred Contracts. 
  
 6.10 WARRANTIES. [...***...]. 
  
  

	*	 	Confidential Treatment Requested 

  
 14 

 6.11 Other Information. This Agreement, the Exhibits, Appendices and Schedules hereto, as
each may be amended prior to the Closing, and all certificates delivered to Buyer and its representatives from Seller at Closing in connection with this Agreement do not and will not contain any untrue statement of any material fact and do not and
when delivered will not omit to state a material fact necessary to make the statement herein or therein not misleading. 
  
 6.12 Transferred Contract Consents. Schedule 4.4 sets forth a correct and complete list of all the Transferred Contracts that require third
party consent to transfer or otherwise assign to Buyer. 
  
 6.13 Revenues. [...***...], Schedule 6.13 represents in all material respects [...***...] the gross revenues of the In Scope Products for the relevant periods set forth in Schedule 6.13.

  
 6.14 Inventory. On the Closing Date, the
inventory included in the Transferred Assets as set forth in Schedule 1.1 is of such a quality to be useable and saleable by Seller in the ordinary course of business. [...***...]. 
  
 Article VII. Conditions to Buyer’s Obligations 

 
 The obligation of Buyer to consummate the transactions contemplated herein
is subject to the satisfaction (or waiver by Buyer) of the conditions set forth below in this Article. 
  
 7.1 Representations and Warranties. Subject to Section 9.2, the representations and warranties of Seller made in this Agreement shall be
true and correct in all material respects as of the Date of Execution and as of the Closing Date with the same effect as if made at and as of the Closing Date, except to the extent such representations and warranties expressly relate to an earlier
time. Seller shall have performed in all material respects its respective covenants and agreements contained in this Agreement and the other Operative Agreements required to be performed at or prior to the Closing. 
  

	*	 	Confidential Treatment Requested 

  
 15 

 7.2 Consents, Approvals and Injunctions. 
  
 (a) Seller shall have obtained or made all consents, approvals, orders,
licenses, permits and authorizations of, and registrations, declarations and filings with, any Governmental Authority or any other Person required to be obtained or made by or with respect to the Transferred Assets in connection with the execution,,
delivery and performance of this Agreement. 
  
 (b) No injunction,
order or decree of any Governmental Authority shall be in effect as of the Closing, and no lawsuit, claim, proceeding or investigation shall be pending or threatened by or before any Governmental Authority as of the Closing, which would restrain,
prohibit or make unlawful the transfer of the Transferred Assets or Assumed Liabilities. 
  
 (c) No action or proceeding challenging the transactions or any provision of this Agreement or the other Operative Agreements shall be pending or threatened against any party. 
  
 (d) No Burdensome Condition shall exist with respect to Buyer in connection
with the transactions contemplated by the Operative Agreements. 
  
 7.3 Governmental Rule. No Governmental Rule shall have been instituted, issued or proposed to restrain, enjoin or prevent the transfer of the Transferred Assets as contemplated hereby or to invalidate, suspend or require
modification of any material provision of any Operative Agreement. 
  
 7.4 Operative Agreements. Seller shall have entered into each of the Operative Agreements to be executed by it and each such Operative Agreement shall be in full force and effect without breach thereunder. 
  
 7.5 Closing Documents. Seller shall have delivered to Buyer the
following documents: 
  
 (a) a certificate of Seller, dated the
Closing Date, to the effect that Seller’s representations and warranties in this Agreement are true and correct and that all actions required to be taken by Seller prior to the Closing have been duly taken; and 
  
 (b) a certificate of the secretary or assistant secretary of Seller, dated
the Closing Date, [...***...]. 
  
 7.6
Proceedings. All corporate and legal proceedings taken by Seller in connection with the execution of the Operative Agreements and the transfer of the Transferred Assets shall be reasonably satisfactory in form and substance to Buyer and
its counsel, and Buyer shall have received all such certified or other copies of all such documents as it shall have reasonably requested. 
  

	*	 	Confidential Treatment Requested 

  
 16 

 Article VIII. Conditions to Seller’s Obligations. 
  
 The obligations of Seller to consummate the transactions contemplated herein
shall be subject to the satisfaction (or waiver by Seller) of the conditions set forth below in this Article. 
  
 8.1 Payment of Purchase Price. The payment of the Purchase Price in the manner specified in Section 1.3, and any other consideration set
forth in Section 1.3 or the other Operative Agreements due at Closing. 
  
 8.2 Representations and Warranties. The covenants, agreements, representations and warranties of Buyer made in this Agreement shall be true and correct in all material respects as of the Date of Execution and as of the Closing
Date with the same effect as if made at and as of the Closing Date. 
  
 8.3 Consents, Approvals and Injunctions. 
  
 (a) Buyer shall have obtained or made all consents, approvals, orders, licenses, permits and authorizations of, and registrations, declarations and filings with, any Governmental Authority or any other Person required to be obtained or made
by or with respect to Buyer in connection with the execution and delivery of this Agreement and the other Operative Agreements and the Closing. 
  
 (b) No injunction, order or decree of any Governmental Authority shall be in effect as of the Closing, and no lawsuit, claim, proceeding or investigation
shall be pending or threatened by or before any Governmental Authority as of the Closing, which would restrain, prohibit or make unlawful the transfer of the Transferred Assets or the Assumed Liabilities or invalidate or suspend any provision of the
Operative Agreements. 
  
 (c) No Burdensome Condition shall exist
with respect to Seller in connection with the transactions contemplated by the Operative Agreements. 
  
 8.4 Operative Agreements. Buyer shall have entered into each of the Operative Agreements to be executed by it and each such Operative
Agreement shall be in full force and effect without breach thereunder. 
  
 8.5 Closing Documents. Buyer shall have delivered to Seller the following documents: 
  
 (a) a certificate of an authorized signatory of Buyer, dated the Closing Date, to the effect that Buyer’s representations and warranties in this
Agreement are true and correct and that all actions required to be taken by Buyer prior to the Closing have been duly taken; and 
  

 17 

 (b) a certificate of the secretary of Buyer, dated the Closing Date, [...***...], certifying
the attached copy of the By-laws of Buyer, the authorization of the execution, delivery and performance of the Operative Agreements and the resolutions adopted by the Board of Directors of Buyer authorizing the actions to be taken by Buyer under the
Operative Agreements. 
  
 8.6 Proceedings. All
corporate and legal proceedings taken by Buyer in connection with the transactions contemplated by the Operative Agreements and all documents and papers relating to such transactions shall be reasonably satisfactory in form and substance to Seller
and its counsel, and Seller shall have received all such certified or other copies of all such documents as it shall have reasonably requested. 
  
 Article IX. General Matters. 
  
 9.1 Survival of Representations and Warranties. All representations and warranties made by the Parties in this Agreement or in any schedule,
document, certificate or other instrument delivered by or on behalf of the Parties pursuant to this Agreement shall survive the Closing for a period of [...***...] after the Closing Date; provided, however, that all
representations and warranties relating to the Assumed Liabilities shall survive the Closing Date until [...***...]. 
  
 9.2 Limitation of Liability. Notwithstanding anything to the contrary set forth in the Operative Agreements, unless this section is
specifically excluded from application to a specific Operative Agreement or provision in an Operative Agreement, Seller shall not be liable for any amounts with respect to the breach of any representations or warranties contained in an Operative
Agreement unless and until such amounts shall exceed in the aggregate [...***...] (the “Limitation Amount”) (in which case [...***...]). Notwithstanding anything to the contrary set forth in the Operative
Agreements, unless this section is specifically excluded from application to a specific Operative Agreement or provision in an Operative Agreement, in no event shall Seller’s liability for any causes of action arising out of, or related to any
representations or warranties contained in the Operative Agreements exceed [...***...] in the aggregate; provided, however, that such limitation shall not be applicable with respect to Seller’s representation set forth in
Section 6.6. 
  
 For purposes of this Section 9.2 only, reference to the Operative
Agreements shall exclude [...***...]. 
  
 Neither Seller nor Buyer
shall be responsible for any indirect, incidental, punitive, special or consequential damages whatsoever, including but not limited to loss of profits ( except to the extent such loss of profits are determined by a court of competent jurisdiction to
constitute direct damages) or goodwill, , even if advised of the possibility of such damages. 
  

	*	 	Confidential Treatment Requested 

  
 18 

 9.3 Public Announcements. The Confidentiality Agreement between the Seller and Buyer
continues to apply, and the Operative Agreements as well as the proposed transaction are subject to and confidential under that Confidentiality Agreement. For [...***...] after the Closing Date, all public announcements in the form of a
Press Release relating to the Operative Agreements or the transactions contemplated hereby shall be made only after consultation between the Parties, except for disclosures by either Party that in the opinion of counsel for such Party are necessary
and proper under applicable law, rule or regulation (but only after the disclosing Party has taken all reasonable steps to advise the other Party about the Party’s intention to make, and the proposed contents of, such disclosures). Any
direct disclosures to customers in connection with commercial relationships shall not reveal the consideration specified in Section 1.3 of this Agreement. Notwithstanding the foregoing, either Party shall have the right, in its sole discretion, to
make such disclosures as it may deem necessary or advisable to any Governmental Authority. In the event of a breach or anticipatory breach of this Section 9.3. by either Party, the other Party shall be entitled, in addition to any and all other
remedies available at law or in equity, to preliminary and permanent injunctive relief and specific performance without proving damages. 
  
 Each of the Parties hereto will rely on their own advisors with respect to advice regarding the tax treatment and structure of the transaction contemplated under this
Agreement. The parties also recognize that under IRS regulations promulgated earlier this year with respect to tax shelters (“Tax Shelter Regulations”), a transaction may be deemed a “confidential transaction” thereunder unless
the related agreements expressly permit the disclosure of the “tax treatment and tax structure” of the transaction. Therefore, notwithstanding anything to the contrary herein or in any other Operative Agreement, each of the parties agree
that the other may disclose all information regarding the “tax treatment and tax structure” of the transaction contemplated under this Agreement, but only to the extent and in the manner required to avoid having the transaction
contemplated under this Agreement be treated as a reportable transaction under the Tax Shelter Regulations. 
  
 9.4 Costs. [...***...]. If any action or proceeding relating to this Agreement or the enforcement of any provision of
this Agreement is brought against any party hereto, the prevailing party shall be entitled to recover reasonable attorneys’ fees, reasonable costs, and reasonable disbursements (in addition to any other relief to which the prevailing party may
be entitled). 
  
 9.5 [...***...]. 
  
 9.6 Modification and Waiver. No modification or waiver of any
provision of this Agreement and no consent by either Party to any departure therefrom shall be effective unless in a writing referencing the particular section of this Agreement to be modified or waived and signed by a duly authorized signatory of
each Party, and the same will only then be effective for the period and on the conditions and for the specific instances and purposes specified in such writing. 
  

	*	 	Confidential Treatment Requested 

  
 19 

 9.7 Governing Law. This Agreement has been delivered at and shall be deemed to have been
made at [...***...], and shall be interpreted, and the rights and liabilities of the Parties hereto determined, exclusively in accordance with the laws of the State of [...***...] applicable to agreements executed, delivered and
performed within such State, without regard to the principles of conflicts of laws thereof. Each of the Parties hereby: (i) waives trial by jury, (ii) waives any objection to [...***...] venue of any action instituted hereunder, and
(iii) consents to the granting of such legal or equitable relief as is deemed appropriate by any aforementioned court. 
  
 9.8 Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given and shall be
effective (a) when delivered by messenger or courier, or (b) five days after deposit for mailing by registered or certified mail, postage prepaid, return receipt requested, when also transmitted by telecopy as follows: 
  

	 	(a)	 	if to Seller, to: 

  
 International Business Machines Corporation 
 New Orchard Road 
 Armonk, New York 10504 
  

[...***...] 
  
 with a copy at the same address to: 
  
 [...***...] 
  

	 	(b)	 	if to Buyer, to: 

 Applied Micro Circuits Corportation

 6290 Sequence Druive 
 San
Diego, CA 92191 
  
 Attention: General Counsel 
  
 [...***...] 
  
 with a copy to: 
  
 Paul, Hastings, Janofsky & Walker 
 3579 Valley Centre Drive 
 San Diego, CA 92130 
  
 [...***...] 
  
 or to such Person or address as the Parties shall hereafter designate to the other from time to time by similar written notice. 
  

	*	 	Confidential Treatment Requested 

  
 20 

 9.9 Bulk Sales. Buyer hereby waives compliance by Seller with any applicable bulk sales or
similar laws. Buyer shall discharge the Assumed Liabilities in accordance with their terms and Buyer agrees that Seller shall have no liability for any failure of Buyer to discharge the Assumed Liabilities in accordance with their terms. 

 
 9.10 Assignment. This Agreement shall be binding upon, and
inure to the benefit of, and be enforceable by, the successors and assigns of the Parties; provided, that, no Party may assign its obligations, rights or privileges, in whole or in part, hereunder without the prior written consent of the
other Party. 
  
 9.11 Counterparts. This Agreement
may be executed by the Parties in one or more counterparts, each of which shall be an original and all of which shall constitute one and the same instrument. Once signed by both parties, any reproduction of this Agreement made by reliable means
(e.g., photocopy or facsimile) is considered an original. 
  
 9.12 No Third Party Beneficiaries. This Agreement is for the sole benefit of the Parties and their permitted successors and assigns and nothing herein expressed or implied shall give or be construed to give any Person, other
than the Parties and such permitted successors and assigns, any legal or equitable rights hereunder. 
  
 9.13 Entire Agreement. This Agreement, together with the other Operative Agreements, comprise the entire agreement between the Parties with
respect to the subject matter hereof and thereof and supersede all prior agreements, understandings and representations, oral or written, between Buyer and Seller relating hereto and thereto. The Parties agree and acknowledge that the parties have
an existing commercial relationship and that nothing in the Operative Agreements shall be construed to impair or limit the rights of the Parties under any other existing agreements between the Parties, and that nothing under any other existing
agreements between the Parties shall be construed to impair or limit the rights of the Parties under the Operative Agreements. 
  

 21 

 THE REST OF THIS PAGE INTENTIONALLY LEFT BLANK 
  

 22 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized
signatories as of the date and year first above written. 
  

	INTERNATIONAL BUSINESS
MACHINES CORPORATION	 	 	 	APPLIED MICRO CIRCUITS
CORPORATION
					
	By:	 	 [. . .***. . .]

	 	 	 	By:	 	 [. . .***. . .] 

					
	 Name:
	 	[. . .***. . .]	 	 	 	 Name:
	 	[. . .***. . .]
	 	
	 	 	 	 	

					
	 Title:
	 	[. . .***. . .]	 	 	 	 Title:
	 	[. . .***. . .]
	 	
	 	 	 	 	

	*	 	Confidential Treatment Requested 

  

 23License Agreement

 Exhibit 10.42 
  
 ***Text Omitted and Filed Separately 
 Confidential Treatment Requested 
 Under C.F.R. §§ 200.80(b)(4) and 240.24b-2

  
 License Reference Number__L034488_______ 

 

	 EXECUTION COPY
	 	PATENT LICENSE AGREEMENT

  
 LICENSE
AGREEMENT (“Agreement”) dated Sept. 28,2003 (“Agreement Date”) between INTERNATIONAL BUSINESS MACHINES CORPORATION, a New York corporation (“IBM”), and APPLIED MICRO CIRCUITS CORPORATION, a Delaware corporation
(“BUYER”). 
  
 WHEREAS, IBM and BUYER have executed
concurrently herewith an “Asset Purchase Agreement” (APA), “Intellectual Property Agreement” (IPA), and other ancillary agreements identified in the APA as the “Operative Agreements” for the purpose of conveying certain
assets and licensing certain intellectual property from IBM to BUYER in a divestiture and acquisition transaction relating to Switch Fabric PRS Products; 
  
 WHEREAS, the use of such assets and the exercise of such licenses may require a license under IBM patents; 
  
 WHEREAS, IBM has the right to license such patents, and BUYER desires to
acquire a [...***...] license under such patents; 
  
 WHEREAS, BUYER has the right to license its own patents, and IBM desires to acquire a [...***...] license under such patents; 
  
 NOW THEREFORE, in consideration of the premises and mutual covenants herein contained, IBM and BUYER (each as “Grantee” and “Grantor”)
agree as follows: 
  
 Section 1. Definitions 
  
 As used herein, the term “Agreement” means this Patent License
Agreement. The following terms used in this Agreement shall have the respective meanings assigned in this Agreement unless the context otherwise requires. Certain capitalized terms used in this Agreement and not otherwise defined shall have the
meanings set forth in the IPA. 
  

	1.1	 	“IBM Licensed Patents” shall mean [...***...] 

  

	*	 	Confidential Treatment Requested 

  
 1 

 [...***...] 
  
 Notwithstanding the foregoing, or any other provision of this Agreement or any other Operative Agreement, IBM Licensed Patents shall expressly exclude
[...***...]. 
  
 IBM Licensed Patents shall include
[...***...]. 
  

	1.2	 	“BUYER Licensed Patents” shall mean [...***...]. 

  
 Notwithstanding the foregoing or any other provision of this Agreement or any other Operative Agreement, Buyer Licensed Patents shall expressly exclude [...***...]

  

	*	 	Confidential Treatment Requested 

  
 2 

 [...***...]. 
  
 BUYER Licensed Patents shall include said [...***...]. 
  

	1.3	 	“IBM Licensed Product” shall mean [...***...]. 

  

	1.4	 	“BUYER Licensed Product” shall mean [...***...]. 

  

	1.5	 	“Licensed Products” shall mean IBM Licensed Products or BUYER Licensed Products as the context indicates. 

  

	1.6	 	“Licensed Software” shall mean the object code and source code for software embedded in or otherwise included in Licensed Products. 

  

	1.7	 	“Subsidiary” of a party hereto or of a third party shall mean a corporation, company or other entity: 

  

	 	(a)	 	more than fifty percent (50%) of whose outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) are, now or
hereafter, owned or controlled, directly or indirectly, by a party hereto or such third party, but such corporation, company or other entity shall be deemed to be a Subsidiary only so long as such ownership or control exists; or

  

	 	(b)	 	which does not have outstanding shares or securities, as may be the case in a partnership, joint venture or unincorporated association, but more than fifty percent (50%) of whose
ownership interest representing the right to make the decisions for such corporation, company or other entity is now or hereafter, owned or controlled, directly or indirectly, by a party hereto or such third party, but such corporation, company or
other entity shall be deemed to be a Subsidiary only so long as such ownership or control exists. 

  

	1.6	 	 “Assigned Product Copyrights”, “Assigned Product Know-how”, “ Chip Carrier”, “Licensed Product Copyrights”, “Chip
Carrier”, “Semiconductor Device”, 

  

	*	 	Confidential Treatment Requested 

  
 3 

	 	 
“Semiconductor Material”, “Semiconductor Product”, “Switch Fabric PRS Product” and “Licensed Product Know-how” shall
have the meanings set forth in the Intellectual Property Agreement. 

  

	1.7	 	“Derivative Work” shall mean a work which is based upon one or more preexisting works, including, but not limited to , a revision, modification, translation, abridgement,
condensation, expansion or any other form which such preexisting work may be recast, transformed or adapted. 

  

	1.8	 	“Effective Date” shall mean Closing Date as identified in the APA. 

  

	1.9	 	“Licensed Patents” shall mean either IBM Licensed Patents or BUYER Licensed Patents as the context indicates. 

  
 Section 2. Grants of Rights 
  

	2.1	 	Each party, as Grantor, on behalf of itself and its Subsidiaries grants to the other, as Grantee, a [...***...] license under Grantor’s Licensed Patents:

 [...***...] 
  
 The license granted by BUYER to IBM is fully paid up. The license granted by IBM to BUYER shall become fully paid up upon the receipt by IBM
of the consideration set forth in Section 4. 
  

	2.2	 	The license granted in Section 2.1(b) [...***...]: 

 [...***...] 
  

	*	 	Confidential Treatment Requested 

  
 4 

 [...***...]. 
  
 Unless Grantee informs Grantor to the contrary, [...***...]. 
  

	2.3	 	Except as expressly provided herein, no license or immunity is granted under this Agreement by either party, either directly or by implication, estoppel or otherwise to any third
parties acquiring items from either party for the combination of such acquired items with other items (including items acquired from either party hereto) or for the use of such combination. 

  

	2.4	 	Subject to Section 2.5, the licenses granted herein shall include the right of each party to grant sublicenses to its Subsidiaries existing on or after the Effective Date, which
sublicenses may include the right of sublicensed Subsidiaries to sublicense other Subsidiaries of said party. No sublicense shall be broader in any respect at any time during the life of this Agreement than the license held at that time by the party
that granted the sublicense. 

  

	2.5	 	A sublicense granted to a Subsidiary shall terminate on the earlier of: 

  

	 	(a)	 	the date such Subsidiary ceases to be a Subsidiary; and 

  

	 	(b)	 	the date of termination or expiration of the license of the party or Subsidiary that granted the sublicense. 

  
 If a Subsidiary ceases to be a Subsidiary and holds any patents under which a party hereto is
licensed, such license shall continue for the term defined herein. 
  

	2.6	 	In the event that neither a party nor any of its Subsidiaries has the right to grant a license under any particular Licensed Patent of the scope set forth in Section 2, then the
license granted herein under said Licensed Patent shall be of the broadest scope which said party or any of its Subsidiaries has the right to grant within the scope set forth above. 

  

	2.7	 	If, after the Effective Date, a party or any of its Subsidiaries (“Acquiring Party”) either acquires an entity or acquires substantially all of the assets from an entity,
and said entity is, immediately prior to the date of acquisition, licensed by the other party (“Licensor”) under one or more Licensed Patents through an existing agreement pursuant to which royalties or other payments are made by said
entity to Licensor, then the license and other rights granted herein to the Acquiring Party with respect to said Licensed Patents shall apply to products manufactured by said entity or through the use of said assets, provided that such royalties or
other payments shall continue to be made by the Acquiring Party or said entity to the Licensor with respect to such products notwithstanding that the Acquiring Party may have been licensed for the same Licensed Products before the acquisition.

  

	*	 	Confidential Treatment Requested 

  
 5 

	2.8	 	Notwithstanding anything said in Section 2 of this Agreement, no license or immunity is granted by Grantor to Grantee, or anyone working under the direction of Grantee, directly or
by implication or estoppel or other wise under any Grantor Licensed Patent to: 

 [...***...] 
  
 Section 3. 
  
 This section intentionally left blank. 
  
 Section 4. Payment 
  

	4.1	 	The license rights granted by BUYER to IBM shall be considered fully paid up by IBM upon execution of this Agreement. The license rights granted by IBM to BUYER shall be considered
fully paid up by BUYER upon payment by BUYER to IBM of all amounts due under the IPA. 

  
 Section 5. Term of Agreement; Acquisition of a Party 
  

	5.1	 	The term of the licenses granted under this Agreement shall be from the Effective Date until the expiration of the last to expire of the Licensed Patent claims , unless earlier
terminated under the provisions of this Agreement. For the avoidance of doubt however, unless there is a Closing, this Agreement shall be null and void ab initio and have no effect. 

  

	5.2	 	Grantor shall have the right to terminate the license and any other rights granted to Grantee under this Agreement, in whole or in part, if: 

  

	 	(a)	 	Grantee fails at any time to make any payment required herein or in the APA; or 

  

	 	(b)	 	Grantee intentionally and materially breaches any term or condition relating to intellectual property misuse or confidentiality provisions under any Operative Agreement, and if
Grantee does not, after written notice specifying the nature of the breach, cure within [...***...]. The termination of this license or rights under this Agreement shall be effective upon written notice. 

  

	*	 	Confidential Treatment Requested 

  
 6 

	5.3	 	If BUYER is acquired by a third party, thereby becoming a Subsidiary of the third party, if BUYER notifies SELLER in writing prior to said acquisition, BUYER may retain its rights
hereunder so long as such acquiring third party accepts the obligations of this Agreement and unless one of the following applies (in which case the Agreement will terminate upon such acquisition): 

  

	 	(a)	 	SELLER has an unresolved intellectual property dispute with said third party; 

  

	 	(b)	 	SELLER has ongoing litigation with said third party in which the claim is for injunctive relief, specific performance or damages in excess of [...***...].

  
 Section 6. Means of Communication 
  

	6.1	 	Notices and other communications shall be sent by facsimile or by registered or certified mail to the following addresses and shall be effective upon mailing:

  

	 For SELLER:
	 	 For BUYER:

	 [...***...]
 IBM Corporation
 North Castle Drive, [...***...]
 Armonk, NY 10504-1785
 United States of America
	 	 [...***...]
 [...***...]
 Applied Micro Circuits Corporation
 6290 Sequence Drive
 San Diego, CA
92121
 United States of America

		
	 Facsimile: [...***...]
	 	Facsimile: [...***...]

  

	6.2	 	A License Reference Number will be assigned to our agreement upon execution. This number should be included in all communications including wire transfer payments, royalty reports,
tax credit certificates, letters, faxes and E-Mail messages. 

  
 Section 7. Miscellaneous 
  

	7.1	 	Neither party shall assign or grant any right under any of its Licensed Patents unless such assignment or grant is made subject to the terms of this Agreement.

  

	7.2	 	Neither party shall assign any of its rights (other than the right to receive payments) or delegate any of its obligations under this Agreement without the other party’s prior
written consent (which shall not be unreasonably withheld). Any attempt to do so shall be void. However, a party which undergoes reorganization may assign its rights and delegate its obligations to its legal successor, provided that after the
reorganization the successor and its Subsidiaries will have essentially the same assets as such party and its Subsidiaries had immediately prior to the reorganization. 

  

	7.3	 	Neither party shall use or refer to this Agreement or any of its provisions in any promotional activity. 

  

	7.4	 	 Each party represents and warrants that it has the full right and power to grant the license set forth in Section 2. Except as set forth in Section 7 of the IPA,
neither party makes any other 

  

	*	 	Confidential Treatment Requested 

  
 7 

	 	 
representation or warranty, express or implied, nor shall either party have any liability in respect of any infringement of patents or other rights of third
parties due to the other party’s operation under the license herein granted. 

  

	7.5	 	Nothing contained in this Agreement shall be construed as conferring any rights by implication, estoppel or otherwise, under any non-patent intellectual property right, or any
patents or patent applications, other than the Licensed Patents. Neither party is required hereunder to furnish or disclose to the other any technical or other information (including copies of Licensed Patents) except as specifically provided
herein. 

  

	7.6	 	Neither party shall have any obligation hereunder to institute any action or suit against third parties for infringement of any of its Licensed Patents or to defend any action or
suit brought by a third party which challenges or concerns the validity of any of its Licensed Patents. Neither party shall have any right to institute any action or suit against third parties for infringement of any of the other party’s
Licensed Patents. Neither party, nor any of its Subsidiaries, is required to file any patent application, or to secure any patent or patent rights, or to maintain any patent in force. 

  

	7.7	 	Each party shall, upon a request from the other party sufficiently identifying any patent or patent application under the control of the requested party, inform the other party as
to the extent to which said patent or patent application is subject to the licenses and other rights granted hereunder. If such licenses or other rights under said patent or patent application are restricted in scope, copies of all pertinent
provisions of any contract or other arrangement creating such restrictions shall, upon request, be furnished to the party making such request, unless such disclosure is prevented by such contract, and in such event, a statement of the nature of such
restriction shall be provided. 

  

	7.8	 	If a third party has the right to grant licenses under a patent to a party hereto (as a “Licensee”) with the consent of the other party hereto, said other party shall
provide said third party with any consent required to enable said third party to license said Licensee on whatever terms such third party may deem appropriate. Each party hereby waives any right it may have to receive royalties or other
consideration from said third party as a result of said third party’s so licensing said Licensee within the scope of the licenses granted under Section 2 of this Agreement. 

  

	7.9	 	This Agreement shall not be binding upon the parties until it has been signed hereinbelow by or on behalf of each party. No amendment or modification hereof shall be valid or
binding upon the parties unless made in writing and signed as aforesaid, except that IBM may amend Section 6.2 and either party may amend its address in Section 6.1 by written notice to the other party. 

  

	7.10	 	 If any section of this Agreement is found by competent authority to be invalid, illegal or unenforceable in any respect for any reason, the validity, legality and
enforceability of such section in every other respect and the remainder of this Agreement shall continue in effect so 

  

 8 

	 	 
long as the Agreement still expresses the intent of the parties. However, if the intent of the parties cannot be preserved, this Agreement shall be either
renegotiated or terminated. 

  

	7.11	 	This Agreement shall be deemed to have been made in [...***...], and all matters arising from or relating in any manner to the subject matter of this Agreement shall be
interpreted, and the rights and liabilities of the parties determined, in accordance with the laws of the State of [...***...] applicable to agreements executed, delivered and performed within such State, without regard to the
principles of conflicts of laws thereof. 

  

	7.12	 	The headings of sections are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement.

  

	7.13	 	Until [...***...], each party agrees not to disclose the terms of this Agreement to any third party (other than its Subsidiaries) without the prior written consent of
the other party. This obligation is subject to the following exceptions: 

  

	 	(a)	 	disclosure is permissible if required by government or court order, provided the party required to disclose first gives the other prior written notice to enable it to seek a
protective order; 

  

	 	(b)	 	disclosure is permissible if otherwise required by law; 

  

	 	(c)	 	disclosure is permissible if required to enforce rights under this Agreement; 

  

	 	(d)	 	each party may use similar terms and conditions in other agreements; and 

  

	 	(e)	 	each party may disclose this Agreement or its contents to the extent reasonably necessary, on a confidential basis, to its accountants, attorneys, financial advisors, its present or
future providers of venture capital and/or potential investors in or acquirers of such party or product lines which qualify under Section 2.9. 

  
 This Agreement embodies the entire understanding of the parties with respect to the Licensed Patents, and replaces any prior oral or written communications between them.

  

	7.14	 	This Agreement may be executed by the parties in one or more counterparts, each of which shall be an original and all of which shall constitute one and the same instrument.

  

	 Agreed to:
 APPLIED MICRO
 CIRCUITS CORPORATION.
	 	 	 	 Agreed to:
         INTERNATIONAL BUSINESS
         MACHINES CORPORATION

					
	By:	 	[...***...]	 	 	 	By:	 	[...***...]
	 Name:
	 	 [...***...]
	 	 	 	 Name:
	 	 [...***...]

	 Title:
	 	 [...***...]
	 	 	 	 Title:
	 	 [...***...]

	 Date:
	 	 September 28, 2003
	 	 	 	 Date:
	 	 September 28, 2003

  

	*	 	Confidential Treatment Requested 

  
 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00058-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00058-of-00352.parquet"}]]